Gene · 1052
Papers3,093
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,093
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cancer-Associated Adipocytes and Breast Cancer: Intertwining in the Tumor Microenvironment and Challenges for Cancer Therapy. | Cancers (Basel) | 2023 | 36765683 | PubTator, text mining | PubMed |
| An optimised protocol for the investigation of insulin signalling in a human cell culture model of adipogenesis. | Adipocyte | 2023 | 36763512 | PubTator, text mining | PubMed |
| Data on the transcriptional response to MESH1 knockdown and mammalian stringent response. | Data Brief | 2023 | 36761407 | PubTator, text mining | PubMed |
| Stabilization of E-cadherin adhesions by COX-2/GSK3β signaling is a targetable pathway in metastatic breast cancer. | JCI Insight | 2023 | 36757813 | PubTator, text mining | PubMed |
| GDF11 inhibits adipogenesis of human adipose-derived stromal cells through ALK5/KLF15/β-catenin/PPARγ cascade. | Heliyon | 2023 | 36755591 | PubTator, text mining | PubMed |
| The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy. | Front Immunol | 2023 | 36733484 | PubTator, text mining | PubMed |
| SUMO Proteomics Analyses Identify Protein Inhibitor of Activated STAT-Mediated Regulatory Networks Involved in Cell Cycle and Cell Proliferation. | J Proteome Res | 2023 | 36723483 | PubTator, text mining | PubMed |
| A data-driven optimization method for coarse-graining gene regulatory networks. | iScience | 2023 | 36698721 | PubTator, text mining | PubMed |
| Targeting splicing factors for cancer therapy. | RNA | 2023 | 36697261 | PubTator, text mining | PubMed |
| Genome-wide characterization of alternative splicing in blood cells of COVID-19 and respiratory infections of relevance. | Virol Sin | 2023 | 36690184 | PubTator, text mining | PubMed |
| Post-Transcriptional Modification by Alternative Splicing and Pathogenic Splicing Variants in Cardiovascular Development and Congenital Heart Defects. | Int J Mol Sci | 2023 | 36675070 | PubTator, text mining | PubMed |
| C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC. | Int J Mol Sci | 2023 | 36675048 | PubTator, text mining | PubMed |
| Application of In Vitro Models for Studying the Mechanisms Underlying the Obesogenic Action of Endocrine-Disrupting Chemicals (EDCs) as Food Contaminants-A Review. | Int J Mol Sci | 2023 | 36674599 | PubTator, text mining | PubMed |
| Targeting Features of Curaxin CBL0137 on Hematological Malignancies In Vitro and In Vivo. | Biomedicines | 2023 | 36672738 | PubTator, text mining | PubMed |
| Emphasis on Adipocyte Transformation: Anti-Inflammatory Agents to Prevent the Development of Cancer-Associated Adipocytes. | Cancers (Basel) | 2023 | 36672449 | PubTator, text mining | PubMed |
| ETS1-HMGA2 Axis Promotes Human Limbal Epithelial Stem Cell Proliferation. | Invest Ophthalmol Vis Sci | 2023 | 36652264 | PubTator, text mining | PubMed |
| Low input capture Hi-C (liCHi-C) identifies promoter-enhancer interactions at high-resolution. | Nat Commun | 2023 | 36650138 | PubTator, text mining | PubMed |
| Astrocytic Cebpd Regulates Pentraxin 3 Expression to Promote Fibrotic Scar Formation After Spinal Cord Injury. | Mol Neurobiol | 2023 | 36633805 | PubTator, text mining | PubMed |
| Identification of biomarkers and outcomes of endocrine disruption in human ovarian cortex using In Vitro Models. | Toxicology | 2023 | 36621641 | PubTator, text mining | PubMed |
| Zebrafish: a convenient tool for myelopoiesis research. | Cell Regen | 2023 | 36595106 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1052/papers?page=21